According to cGMP regulations separate facility for Cephalosporin is required to prevent cross contamination with other penicillin products or non beta-lactum products. Unintended exposure with Cephalosporin products may cause health concern to patients sensitive to Cephalosporins.

Incepta is the first national company in Bangladesh to build a dedicated state-of-the-art Cephalosporin facility. Incepta currently produces tablets, capsules, dry powder suspensions and injectables in this facility.

Some of the high quality cephalosporin brands that are produced by this pioneer facility include:

• Adora – Cefadroxil
• Cefepime – Ultrapime
• Cefixime – Emixef
• Cefpodoxime – Ximeprox
• Cefradine – Procef
• Ceftazidime – Sidobac
• Ceftriaxone – Exephine
• Cefuroxime – Kilbac